Management of Extraglandular Manifestations of Primary Sjogren's Syndrome

被引:5
|
作者
Wu, Jason J. [1 ,2 ]
Carsons, Steven E. [1 ,3 ]
机构
[1] Winthrop Univ Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Mineola, NY 11501 USA
[2] Nassau Cty Med Ctr, E Meadow, NY 11554 USA
[3] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA
关键词
Sjogren's syndrome; Joint pain; NSAIDs; Anti-TNF; POLYUNSATURATED FATTY-ACIDS; DOUBLE-BLIND; CLINICAL-SIGNIFICANCE; RHEUMATOID-ARTHRITIS; FATIGUE; INVOLVEMENT; RITUXIMAB; VASCULITIS; EFFICACY;
D O I
10.1016/j.coms.2013.09.009
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Primary Sjogren's syndrome can have multiple extra-glandular manifestations ranging from mild to severe. Treatment for extra-glandular manifestations is organ specific and therapies are targeted based on the primary organs involved. Preferred treatment options used for extra-glandular manifestations of Sjogren's syndrome are usually extrapolated from the physician's experience in treating similar manifestations in other autoimmune conditions such as rheumatoid arthritis and systemic lupus erythematous. The lack of immunomodulating disease modifying drugs in Sjogren's syndrome can be frustrating for patients dealing with extra-glandular manifestations, however recent advances in the field has made the future look promising for new therapeutic options.
引用
收藏
页码:101 / +
页数:10
相关论文
共 50 条
  • [21] Clinical manifestations of neurological involvement in primary Sjogren's syndrome
    Gono, Takahisa
    Kawaguchi, Yasushi
    Katsumata, Yasuhiro
    Takagi, Kae
    Tochimoto, Akiko
    Baba, Sayumi
    Okamoto, Yuko
    Ota, Yuko
    Yamanaka, Hisashi
    CLINICAL RHEUMATOLOGY, 2011, 30 (04) : 485 - 490
  • [22] Primary Sjogren's syndrome: The challenge for classification of disease manifestations
    Oxholm, P
    Asmussen, K
    JOURNAL OF INTERNAL MEDICINE, 1996, 239 (06) : 467 - 474
  • [23] Meta-Analysis of Treatment for Primary Sjogren's Syndrome
    Chu, Lucy L.
    Cui, Kangping
    Pope, Janet E.
    ARTHRITIS CARE & RESEARCH, 2020, 72 (07) : 1011 - 1021
  • [24] Development and Application of the Placebo Response Model in Clinical Trials for Primary Sjogren's Syndrome
    Wang, Zhi-Zhou
    Zheng, Qing-Shan
    Liu, Hong-Xia
    Li, Lu-Jin
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [25] Pulmonary Manifestations of Primary Sjogren's Syndrome: Underlying Immunological Mechanisms, Clinical Presentation, and Management
    Gupta, Sarthak
    Ferrada, Marcela A.
    Hasni, Sarfaraz A.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [26] Primary Sjogren's syndrome
    Rischmueller, Maureen
    Tieu, Joanna
    Lester, Susan
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2016, 30 (01): : 189 - 220
  • [27] Renal involvement in primary Sjogren's syndrome
    Evans, Rhys
    Zdebik, Anselm
    Ciurtin, Coziana
    Walsh, Stephen B.
    RHEUMATOLOGY, 2015, 54 (09) : 1541 - 1548
  • [28] Rituximab Therapy for Primary Sjogren's Syndrome
    Chen, Yi Han
    Wang, Xin Yu
    Jin, Xin
    Yang, Zi
    Xu, Jianguang
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [29] Rituximab Therapy in Primary Sjogren's Syndrome
    Alcantara, Cristina
    Gomes, Maria Joao
    Ferreira, Carlos
    CONTEMPORARY CHALLENGES IN AUTOIMMUNITY, 2009, 1173 : 701 - 705
  • [30] Emerging drugs for primary Sjogren's syndrome
    Gandolfo, Saviana
    De Vita, Salvatore
    EXPERT OPINION ON EMERGING DRUGS, 2019, 24 (02) : 121 - 132